US 11351182
Vaginal inserted estradiol pharmaceutical compositions and methods
granted A61KA61K31/565A61K31/57
Quick answer
US patent 11351182 (Vaginal inserted estradiol pharmaceutical compositions and methods) held by Compass Therapeutics LLC expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/565, A61K31/57, A61K47/14, A61K9/0036